Rebecca North

College of Sciences

Works (3)

Updated: July 5th, 2023 14:31

2021 article

Sex-Differences in Cause of Death for Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction (from the ASCEND-HF Trial)

Chow, C., Greene, S. J., North, R., Blumer, V., Truby, L. K., Alhanti, B., … Mentz, R. J. (2021, September 1). AMERICAN JOURNAL OF CARDIOLOGY, Vol. 154, pp. 123–126.

By: C. Chow *, S. Greene *, R. North n, V. Blumer *, L. Truby *, B. Alhanti*, J. Butler *, J. Ezekowitz *, R. Starling *, R. Mentz *

MeSH headings : Aged; Aged, 80 and over; Cardiovascular Diseases / mortality; Case-Control Studies; Cause of Death; Death, Sudden, Cardiac / epidemiology; Female; Heart Failure / mortality; Heart Failure / physiopathology; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction / mortality; Pulmonary Embolism / mortality; Sex Distribution; Sex Factors; Stroke / mortality; Stroke Volume; Ventricular Dysfunction, Left / physiopathology
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: September 7, 2021

2021 article

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial

Norgren, L., North, R., Baumgartner, I., Berger, J. S., Blomster, J. I., Hiatt, W. R., … Fowkes, F. G. R. (2021, September 13). VASCULAR MEDICINE.

By: L. Norgren *, R. North n, I. Baumgartner *, J. Berger *, J. Blomster*, W. Hiatt *, W. Jones *, B. Katona * ...

author keywords: epidemiology; geographical variation; outcome; peripheral artery disease (PAD); prevention; risk factors
MeSH headings : Clopidogrel / therapeutic use; Humans; Internationality; Ischemia / drug therapy; Ischemic Stroke / epidemiology; Myocardial Infarction / epidemiology; Peripheral Arterial Disease / diagnosis; Peripheral Arterial Disease / drug therapy; Peripheral Arterial Disease / epidemiology; Ticagrelor / therapeutic use; Treatment Outcome
TL;DR: Substantial regional differences were found in cardiovascular and limb outcomes in patients with PAD and were not explained by variation in the category of included patients, concomitant disease, risk factors, and prevention. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: September 20, 2021

2020 journal article

VVI pacing with normal QRS duration and ventricular function: MOST trial findings relevant to leadless pacemakers

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 43(12), 1461–1466.

By: Z. Loring *, R. North n, A. Hellkamp *, B. Atwater *, C. Frazier-Mills*, K. Jackson *, S. Pokorney *, G. Lamas *, J. Piccini *

author keywords: atrial fibrillation; heart failure; leadless pacing; outcomes; pacemaker
MeSH headings : Aged; Aged, 80 and over; Atrial Fibrillation / physiopathology; Atrial Fibrillation / therapy; Cardiac Pacing, Artificial / methods; Equipment Design; Female; Humans; Male; Pacemaker, Artificial; Sick Sinus Syndrome / physiopathology; Sick Sinus Syndrome / therapy; United States
TL;DR: The Mode Selection Trial in Sinus Node Dysfunction (MOST) showed similar outcomes in patients randomized to dual‐chamber (DDDR) versus ventricular pacing (VVIR) compared to outcomes by pacing mode in LP‐eligible patients from MOST. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: November 24, 2020

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2025) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.